Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 2 Ovarian Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Endometrial Hyperplasia 1

Interventions

Megestrol Acetate 5 Tirzepatide 2 Progestins 2 Metformin 2 Biopsy 2 Atorvastatin 2 exemestane 1 estradiol, norethindrone drug combination 1 Rosuvastatin Calcium 1 Pterocarpus marsupium 1 Progesterone 1 Pharmacogenomic Variants 1 Medroxyprogesterone Acetate 1 Levonorgestrel 1 Hysterectomy 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Everolimus 1 Curettage 1 3,5-dimethoxy-4'-hydroxystilbene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Endometrial Hyperplasia × Levonorgestrel × Clear all

NCT01686126 2024-08-28

feMMe

Queensland Centre for Gynaecological Cancer

Phase 2 Active not recruiting

Endometrial Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡